Posts Tagged ‘Sibutramine’
Anti obesity drug Sibutramine withdrawn from US markets due to adverse cardiovascular risk
Posted by: admin on: July 22, 2011
Abbott Laboratories has withdrawn the obesity drug Sibutramine (Meridia) from the market in light of clinical trial data pointing to an increased risk for stroke and myocardial infarction, the US Food and Drug Administration (FDA) announced. The agency asked Abbott Laboratories to pull the drug from the market after it evaluated data from a […]
Sibutramine, the obesity drug, loses its weight
Posted by: admin on: May 5, 2011
For once, Indian Government has acted fast and has banned Sibutramine due to serious cardiovascular risks in users. We need a strict watchdog to take similar action on drugs that cause more side effects than actual effects. Team@CMHF
Tags: Sibutramine, Weight loss
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
